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Abstract
Background: The assessment of personality disorders (PD) is costly and time-consuming. There is a need for a
brief screen for personality disorders that can be used in routine clinical settings and epidemiological surveys.
Aims: To test the validity of the Standardised Assessment of Personality: Abbreviated Scale (SAPAS) as a screen for
PD in a clinical sample of substance abusers.
Methods: Convergent validity of the SAPAS with both categorical and dimensional representations of personality
disorders was estimated.
Results: In this sample, the SAPAS correlated well with dimensional representations of cluster A and C personality
disorders, even after controlling for ADHD symptoms, anxiety/depression symptoms and recent substance use. The
SAPAS was also significantly associated with total number of PD criteria, although correlation with categorical
measures of PD was weak.
Conclusions: The SAPAS is an valid brief screen for PD as assessed dimensionally.
Background
Personality pathology is common among substance
dependent patients [1]. Substance dependent patients
display the full range of personality disorders, and these
diverse disorders predict impairment in different areas
of functioning [2]. A growing body of research suggests
that a dual focus on both personality disorder and sub-
stance use disorder is superior to treatment that focuses
only on the substance use disorder itself (e.g [3]).
The Structured Assessment of Personality Abbreviated
Scale (SAPAS) is an eight-item screening interview for
personality disorder [4]. Its purpose is to produce a
dimensional score that represents the likelihood that a
person has a personality disorder in general, rather than
to screen for particular types of personality disorders or
patterns. It produces a score that ranges from 0 to 8. In
the original study with psychiatric patients, a score of 3
or more was both sensitive and specific as a measure of
the presence of a personality disorder according to the
Structured Clinical Interview for the DSM-IV- Axis II
[4]. It was designed to be so brief that it could be used
in both routine clinical assessment when pressed for
time, and potentially in community surveys.
In a previous study of a Danish population, it was
found that the SAPAS correlated with staff-ratings of
externalizing behaviour and global assessment of func-
tioning in a methadone maintenance clinic [6]. How-
ever, while the previous study assessed correlations with
functioning, it did not assess convergent validity with
other measures of personality disorders. The original
study of the SAPAS tested the value of the instrument
as a measure of personality disorder in a psychiatric
sample, but did not test associations with other problem
areas, such as functioning, symptoms of anxiety or
depression, or attention deficit-hyperactivity disorder
[4]. Thus, neither study has assessed the possibility that
the SAPAS as a measure of personality pathology is con-
founded by other psychopathology. * Correspondence: mh@crf.au.dk
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dence of axis II disorders from axis I disorders [5]. As
axis II disorders share a range of properties with axis I
disorders, such as impaired functioning, difficulty in
decision making and subjective well-being, it is impor-
tant that screening tools designed to study the presence
of personality disorders have discriminant validity
against axis I disorders. This has not yet been studied
for the SAPAS in any language.
In addition, it is unclear how well the SAPAS mea-
sures the full range of personality pathology. The DSM-
IV lists 10 different personality disorders (plus 3 appen-
dix disorders for further study) [8], and the SAPAS may
have greater salience for some specific areas of personal-
ity pathology
The aim of the present study was to examine the con-
vergent validity of the SAPAS with structured interviews
from both a categorical and a dimensional perspective,
using a different sample than those in the original study.
Specifically, we wanted to study the following questions:
￿ Is the SAPAS associated with dimensional scores
representing personality disorder in general, defined
as the total number of axis II criteria met?
￿ Is this association robust across individual disor-
ders, and the three clusters of the DSM-IV?
￿ Is this association robust after controlling for gen-
der, age, current symptoms of anxiety and depres-
sion, symptoms of attention-deficit hyperactivity
disorder, and recent substance use?
Methods
Procedure
We set out to examine the concurrent validity of a
mini-interview for personality disorder Structured
Assessment of personality - Abbreviated Scale [4]. In
o r d e rt od ot h i s ,w ec o n d u c t e das e r i e so fs e c o n d a r y
analyses of data from a randomized controlled trial of
personality disorder psychoeducation for substance use
disorders. The subjects for this paper were patients ran-
domized to the experimental condition in the study (n =
36), and 18 training cases. The 36 experimental cases
were taken from consecutive admissions to the Centra-
lized intake units where the randomized study took
place. The 18 cases consisted of 10 cases who were
admitted shortly before the trial began, plus 8 volunteers
who were assessed for other purposes as part of their
treatment for substance use disorders, who agreed to
give consent for the use of their data for research
purposes.
Subjects were approached by their caseworkers, and
informed that they had the option to be assessed for
personality disorders and other psychopathology as part
of an ongoing study. Those who agreed were referred to
a research technician, who explained the rationale of the
study.
Subjects gave consent to participate in the study no
earlier than 24 hours after being informed of the pur-
pose of the study by the research technician. The sub-
jects were told that the data collected for the study
would be used for research purposes, and at the same
time be used for their treatment. After assessment, sub-
jects were first given an individual feedback about the
results of the assessment, and then, if they expressed
their interest in this, this feedback was passed on to
their caseworker. Subjects were also informed that with-
out their consent, no information from the interviews
would be passed on to any third party.
The interviews were conducted on two different days.
On the first day, the SAPAS, and all of the non-person-
ality related instruments were administered, and on the
second interview day, the AUDADIS, the PRISM and
the NPI-16 were administered (see below for instrument
descriptions).
Sample description
The sample was 85% male, and the mean age was 32.5
( r a n g e :1 9t o5 4 ) .A m o n gt h er e s p o n d e n t s ,7 4 %h a d
used alcohol in the last 30 days before interview, 66%
had used cannabis, 9% amphetamine, 30% cocaine, 11%
heroin or other opiates, and 6% benzodiazepines. All
patients in the sample scored 3 or more on the Severity
of Dependence scale, indicating substance dependence.
The mean score for the Kessler 6 was 10.8 (range: 0 to
21), indicating elevated scores on depression and anxi-
ety. The mean score for the ADD scale was 19.7 (range
2 to 34), where scores above 23 indicate likely ADD.
The mean for the hyperactivity scale was 17.0 (range:
7 to 34) where scores above 23 indicate likely hyperac-
tivity disorder.
Measures
The Structured Assessment of Personality Abbreviated
Scale (SAPAS) is an eight-item screening interview for
personality disorder [4]. Each item is worded as a ques-
tion to be answered with yes or no (e.g., item 1: “In gen-
eral, do you have difficulty making and keeping
friends?”). When the response is given that indicates
pathology (i.e., yes to item 1), the interviewer must fol-
low up by asking if that is true in general. With eight
yes/no questions followed by up to eight follow-up
questions, the SAPAS will normally be completed in less
than a minute. As the SAPAS is a set of indicators cov-
ering multiple areas, it is not designed to be unidimen-
sional. Rather, the SAPAS is designed to cover different
areas of personality.
The Kessler 6 (K6) is a 6-item interview. Each question
starts with the expression “How often in the past month
did you feel ...” and offers specific symptoms such as
“restless or fidgety,”“ nervous,” and “so depressed that
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range from “none of the time” to “all of the time” and are
scored from 1 to 5; the items are summed to obtain a
total score. The K6 has been found to correlate substan-
tially with both the Comprehensive International Diag-
nostic Interview-Short Form and the World Health
Organization Disability Assessment Schedule [14]. Inter-
nal consistency alpha for the present sample was 0.79.
The Adult ADHD Self-Report Scale (ASRS) [15] is an
18-item self-report scale used to screen for adult symp-
toms of attention-deficit hyperactivity disorder. The
ASRS has been found to possess excellent validity [15],
including convergence with predicted genetic risk mar-
kers for ADHD [16]. For the present sample, the inter-
nal consistency alpha was 0.84 for attention deficit
symptoms and 0.74 for hyperactivity symptoms.
The Psychiatric Research Interview for Substance and
Mental Disorders (PRISM) interview is a semi-struc-
tured interview assessing a range of disorders that are
commonly co-morbid with substance use disorders.
Each item is assessed by asking a question, and when
positive answers are given, follow-up questions are
asked to assess the severity and persistence of a symp-
tom. Each item is scored as 1 (absent), 2 (sub-threshold)
or 3 (clinically significant). The PRISM has demon-
strated validity for antisocial and borderline personality
disorder (e.g [12]). In the present study, we assessed the
interrater reliability of 27 taped interviews. For indivi-
dual criteria for borderline personality disorder, the
average interrater agreement assessed as intraclass cor-
relation ranged from 0.66 to 0.98. For the number of
criteria satisfied, the intraclass correlation was 0.93. For
individual antisocial personality disorder criteria, the
intraclass correlation for individual items ranged from
0.63 to 0.98, and the intraclass correlation for number
of criteria satisfied was 0.98.
T h eA l c o h o lU s eD i s o r d e ra n dAssociated Disabilities
interview Schedule-IV (AUDADIS-IV) is a fully struc-
tured interview covering a range of disorders, including
personality disorders. At the time of this study, only the
proportions of the interview that covered avoidant,
dependent, obsessive-compulsive, paranoid, schizoid,
histrionic and antisocial personality disorder were pub-
lished. The AUDADIS has demonstrated validity and
reliability [13], although it has rarely been used in clini-
cal samples. The AUDADIS asks one or more questions
for each criterion for Axis II, and given an affirmative
answer, the interviewer must ask “Did this ever trouble
you or cause problems at work or school, or with your
family or other people?” Since these questions must be
answered yes or no, there is no clinical judgement with
regard to the interview, and interrater reliability of the
recordings was not assessed. Internal consistency alpha
based on tetrachoric correlations for the present sample
ranged from 0.69 to 0.94 for the AUDADIS scales.
The Narcissistic Personality Inventory-16 (NPI-16)
[12] is an abbreviated version of the Narcissistic Person-
ality Inventory. The NPI uses a forced-choice format
with a narcissistic and a non-narcissistic response for
each item (e.g., “I am apt to show off if I get the chance”
and “It r yn o tt ob eas h o wo f f ”). The 16-item version
was developed to capture the different aspects of narcis-
sism measured by the original NPI, and has excellent
convergent validity with the original version, and good
predictive validity [12]. Internal consistency alpha based
on tetrachoric correlations for the NPI in this sample
was 0.83.
Analyses
For the patients (n = 54) who completed both the SAPAS
and the full personality disorder assessment, we esti-
mated the agreement between the SAPAS with the cut-
off of 3 or more based on the original article [4]. We also
correlated the Spearman rank-order correlations between
the SAPAS and number of personality disorder criteria
by cluster (excluding schizotypal and narcissistic person-
ality disorder), and for each individual criterion. We
report correlations of 0.1-0.3 as low, 0.3-0.5 as moderate,
and correlations >0.5 as large, following Cohen [17].
We conducted a series of linear regressions to assess
the association between the SAPAS and number of per-
sonality disorder criteria controlling for various con-
founders, one for each cluster, and one for total number
of personality disorder criteria. In each regression, the
dependent variable was symptom count for personality
disorders (by cluster, or in total). The covariates were
age, gender, and severity of anxiety or depression symp-
tomatology as measured by the Kessler 6 interview, and
severity of attention deficit problems and hyperactivity
as measured by the ADHD Self-Report Scale.
I nt e r m so fn u m b e ro fc r i t e r i a ,w eu s e dt h es u m so f
the PRISM borderline and antisocial and AUDADIS his-
trionic personality for cluster B pathology, the sum of
avoidant, dependent and obsessive-compulsive personal-
ity disorder criteria for cluster C pathology, and the sum
of paranoid and schizoid personality disorder criteria for
cluster A pathology.
The NPI is not a diagnostic instrument per se, and
while it has been shown to predict important indicators
of narcissistic pathology, we did not include the NPI as
a part of cluster B pathology in the analyses.
Ethics
Danish IBRs do not evaluate studies that do not involve
invasive procedures or the manipulation of pharma-
cotherapy or diet. Dr. Peter Ege, senior consultant of
social medicine in the City of Copenhagen, did an infor-
mal review of the ethical implications of the study.
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Categorical agreement with diagnostic interview
Among the 54 patients in the sample, the most common
personality disorders were antisocial (PRISM, 52%),
paranoid (AUDADIS, 44%), borderline (PRISM, 41%),
and histrionic (AUDADIS, 37%) personality disorder.
Of the 54 patients who could be included in this ana-
lysis, 35 (65%) scored 3 or more on the SAPAS, and 49
(91%) received a diagnosis of at least one personality
disorder based on either the PRISM (borderline or anti-
social) or the AUDADIS interview (other personality
disorders). The agreement was statistically significant (
= 0.22, p = 0.02) although was weak.
Dimensional agreement between number of SAPAS items
endorsed and number of personality disorder criteria
satisfied
The correlations between the SAPAS and the criteria
count for each personality disorder and by cluster are
summarized in table 1. Correlations varied substantially.
Correlations between the SAPAS and paranoid and avoi-
dant personality disorder features were large, and statis-
tically significant. The correlations between the SAPAS
and schizoid, dependent and borderline personality dis-
order were moderate.
Correlations between the SAPAS and antisocial, his-
trionic and obsessive-compulsive personality disorder
were non-significant and low. Also shown in table 1 is
the Spearman correlation between the SAPAS and the
NPI-16, also low (-0.02).
Regression of SAPAS on criteria for personality disorders
After controlling for gender, age and symptoms of anxi-
ety and depression as measured by the Kessler 6
interview [14], and hyperactivity and attention deficit
disorder on the ADHD Self-Report Scale [15], the
SAPAS remained significantly associated with total
number of PD criteria (p = 0.03), and with number of
cluster A criteria (p = 0.003) and cluster C criteria (p =
0.01), but not cluster B criteria (p = 0.95) (see table 2).
In the multivariate analyses, cluster A criteria were addi-
tionally associated with attention disorder (p = 0.02),
cluster B criteria were associated only with hyperactivity
severity (p = 0.006), and cluster C criteria were addition-
ally associated with symptoms of anxiety and depression
(p = 0.03), and low degree of substance use (p = 0.03).
Discussion
As a dimensional measure of the construct of personal-
ity disorder, the SAPAS possesses several attractive
properties: it correlates highly with the number of inter-
view-based criteria for personality disorder, and this cor-
relation remains significant even after controlling for
gender, age, symptoms of anxiety and depression, atten-
tion-deficit hyperactivity disorder symptoms, and recent
substance use. The associations between the SAPAS and
cluster A and C disorders were also robust across all
confounders tested.
However, it also has important limitations: the SAPAS
does not cover the full range of personality disorders
equally well. It does not correlate highly with antisocial,
histrionic and obsessive-compulsive personality disorder,
and with trait narcissism.
Some other correlates of personality disorder severity
deserve comment. These other correlates of personality
disorder criteria varied by cluster. Cluster A criteria
(paranoid and schizoid) showed an independent associa-
tion with attention disorder type symptoms. Previous
research has shown an elevated risk of all types of per-
sonality disorder across types of personality disorders
[17].
The current study also has important limitations. The
focus on borderline and antisocial pathology meant that
we chose an instrument that is different from the instru-
ment used for the other disorders, the AUDADIS.
Hyperactivity type symptoms were significantly asso-
ciated with cluster B disorders. Borderline and antisocial
personality disorders are both believed to share a num-
ber of features with the full ADHD syndrome, and in
particular with the hyperactivity part of ADHD [18].
Prospective research suggests that ADHD is commonly
a precursor of borderline and antisocial personality dis-
orders [19].
Some limitations must be acknowledged. This study is
limited to substance abusers seeking outpatient treat-
ment. However, given existing evidence from psychiatric
patients and methadone maintenance treatment, the
present study adds to our confidence in the validity of
Table 1 Rank-order correlations between personality
disorder criteria counts and the SAPAS (N = 54) (based
on AUDADIS except as indicated)
Rho Probability
Cluster A criteria 0.58 0.00
Paranoid 0.53 0.00
Schizoid 0.40 0.00
Cluster B criteria 0.39 0.00
Antisocial
1 0.04 0.78
Histrionic 0.26 0.06
Borderline
2 0.47 0.00
Cluster C criteria 0.59 0.00
Avoidant 0.55 0.00
Dependent 0.48 0.00
Obsessive-compulsive 0.25 0.06
Total number of personality disorder criteria
3 0.61 0.00
NPI-16 -0.02 0.87
1PRISM-interview adult symptoms only.
2PRISM-interview.
3Across both AUDADIS and PRISM.
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the present study. However, given the focus on conver-
gent validity, weak to moderate correlations that are not
robust to the influence of covariates is unacceptable.
Conclusions
In summary, we found the SAPAS was an acceptable
screen for the odd/eccentric and anxious/fearful dimen-
sions of PD, although it performed less satisfactorily for
the domain of dramatic/impulsive personality distur-
bance. It is likely that a dimensional classification system
for personality disorder will be introduced in DSM-V
[19] and in the light of this, the SAPAS could be of
great value to both clinicians and researchers as a screen
for personality disturbance.
Conflicts of interests
The authors declare that they have no competing
interests.
Acknowledgements
This study was supported by a grant from the Danish Health Insurance Fund
(Grant # 2007D202). Senior consultant in social medicine Dr. Peter Ege,
reviewed the ethical considerations for the study.
Author details
1Centre for Alcohol and Drug Research, University of Aarhus, Denmark.
2Health Services and Population Research Department, Institute of Psychiatry,
King’s College London, UK.
Authors’ contributions
MH organized the study. Both authors planned the current report, MH
conducted the statistical analyses, and drafted the manuscript. PM reviewed
the manuscript, and both authors revised the manuscript several times in
conjunction.
Received: 10 September 2009
Accepted: 28 January 2010 Published: 28 January 2010
References
1. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP: Co-
occurrence of 12-month alcohol and drug use disorders and personality
disorders in the United States: results from the National Epidemiologic
Survey on Alcohol and Related Conditions. Archives of General Psychiatry
2004, 61:361-8.
2. Jansson I, Hesse M, Fridell M: Influence of personality disorder features on
social functioning in substance-abusing women five years after
compulsive residential treatment. European Addiction Research 2009,
15:25-31.
3. Nielsen P, Rojskjaer S, Hesse M: Personality-guided treatment for alcohol
dependence: a quasi-randomized experiment. American Journal on
Addictions 2007, 16:357-64.
4. Moran P, Leese M, Lee T, Walters P, Thornicroft G, Mann A: Standardised
Assessment of Personality - Abbreviated Scale (SAPAS): preliminary
validation of a brief screen for personality disorder. British Journal of
Psychiatry 2003, 183:228-32.
5. Widiger TA, Simonsen E, Krueger R, Livesley WJ, Verheul R: Personality
disorder research agenda for the DSM-V. Journal of Personality Disorders
2005, 19:315-338.
6. Hesse M, Rasmussen J, Pedersen MK: Standardised assessment of
personality - a study of validity and reliability in substance abusers. BMC
Psychiatry 2008, 8:7.
7. American Psychiatric Association: Diagnostic and Statistical Manual Text
Revision. Washington D. C.: American Psychiatric Association 2000.
8. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al:
Screening for Serious Mental Illness in the General Population. Archives
of General Psychiatry 2003, 60:184-194.
9. Darke S, Hall W, Wodak A, Heather N, Ward J: Development and validation
of a multi-dimensional instrument for assessing outcome of treatment
among opiate users: the Opiate Treatment Index. British Journal on
Addictions 1992, 87:733-42.
10. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al: The Severity
of Dependence Scale (SDS): psychometric properties of the SDS in
English and Australian samples of heroin, cocaine and amphetamine
users. Addiction 1995, 90:607-14.
11. Ruan WJ, Goldstein RB, Chou SP, Smith SM, Saha TD, Pickering RP, et al: The
alcohol use disorder and associated disabilities interview schedule-IV
(AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk
factors in a general population sample. Drug and Alcohol Dependence
2008, 92:27-36.
12. Ames DR, Rose P, Anderson CP: The NPI-16 as a short measure of
narcissism. Journal of Research in Personality. 2003, 40:440-50.
13. Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R:
Diagnosing comorbid psychiatric disorders in substance abusers: validity
of the Spanish versions of the Psychiatric Research Interview for
Substance and Mental Disorders and the Structured Clinical Interview
for DSM-IV. American Journal of Psychiatry 2004, 161:1231-7.
14. Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al:
Screening for serious mental illness in the general population. Archives of
General Psychiatry 2003, 60:184-9.
Table 2 Multivariate associations between SAPAS scores and number of PD criteria by cluster (N = 52)
A (odd-eccentric) B (dramatic-erratic) C (anxious-fearful) Total PD
Beta T(44) Beta T(44) Beta T(44) Beta T(44)
SAPAS 0.42 **3.20 0.01 0.06 0.28 *2.54 0.26 *2.24
K6 0.02 0.15 0.12 0.67 0.30 *2.29 0.19 1.38
ADD 0.40 *2.37 -0.04 -0.18 0.19 1.31 0.20 1.29
Hyperactivity 0.08 0.59 0.46 **2.87 0.14 1.19 0.29 *2.37
OTI drug and alcohol use 0.02 0.20 -0.12 -0.88 -0.21 *-2.24 -0.14 -1.35
Gender -0.17 -1.43 0.16 1.16 0.13 1.28 0.07 0.68
Age 0.09 0.78 0.04 0.32 -0.04 -0.44 0.03 0.30
Total R
2adjusted for degrees of
freedom
0.42 0.20 0.59 0.53
F(7,44) ***6.32 *2.79 ***11.59 ***9.25
Notes: Beta values represent association between SAPAS and number of criteria for personality disorder in cluster. K6: Kessler 6. ADD: Attention Deficit Disorder
score. * p < 0.05. ** p < 0.01.
Hesse and Moran BMC Psychiatry 2010, 10:10
http://www.biomedcentral.com/1471-244X/10/10
Page 5 of 615. Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, et al:
Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult
ADHD symptoms. Annals of Clinical Psychiatry 2006, 18:145-8.
16. Halleland H, Lundervold AJ, Halmoy A, Haavik J, Johansson S: Association
between catechol O-methyltransferase (COMT) haplotypes and severity
of hyperactivity symptoms in adults. American Journal of Medical Genetics
Part B: Neuropsychiatric Genetics 2009, 150B:403-10.
17. Cohen J: Statistical power analysis for the behavioral sciences. New
Jersey: Lawrence Erlbaum, 2 1988.
18. Miller TW, Nigg JT, Faraone S: Axis I and II Comorbidity in Adults With
ADHD. Journal of Abnormal Psychology 2007, 116:519-28.
19. Miller CJ, Miller SR, Newcorn JH, Halperin JM: Personality characteristics
associated with persistent ADHD in late adolescence. Journal of Abnormal
Child Psychology 2008, 36:165-73.
20. Skodol AE, Bender DS: The future of personality disorders in DSM-V?.
American Journal of Psychiatry 2009, 166:388-91.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1471-244X/10/10/prepub
doi:10.1186/1471-244X-10-10
Cite this article as: Hesse and Moran: Screening for personality disorder
with the Standardised Assessment of Personality: Abbreviated Scale
(SAPAS): further evidence of concurrent validity. BMC Psychiatry 2010
10:10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Hesse and Moran BMC Psychiatry 2010, 10:10
http://www.biomedcentral.com/1471-244X/10/10
Page 6 of 6